Venus Concept, Inc. is a global medical technology company, which engages in the business of developing, commercializing, and selling minimally invasive and non-invasive medical aesthetic and hair restoration technologies. The company is headquartered in Toronto, Ontario and currently employs 292 full-time employees. The company went IPO on 2017-10-12. The firm develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services and reaches over 60 countries and nine direct markets. The Company’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Its treatments for hair loss are divided into non-surgical options and surgical procedures. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Its systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family medicine and general practitioners and aesthetic medical spas.
VERO'ün son EPS'si beklentilerle karşılaştırıldığında nasıldı?
Venus Concept Inc'in en son EPS'si $-12.14 olup, $-3.68 beklentilerini 뛰어넘지 못한.
Venus Concept Inc VERO'ün son çeyrekteki geliri nasıl performans gösterdi?
Venus Concept Inc'in son çeyrek geliri $-12.14
Venus Concept Inc'in gelir tahmini nedir?
4 Wall Street analistine göre, Venus Concept Inc'in gelir tahmini $15.75M ile $14.7M arasında değişmektedir.
Venus Concept Inc'in kazanç kalite puanı nedir?
Venus Concept Inc'in kazanç kalite puanı B+/48.937904'dir. Puan, karlılık, büyüme, nakit üretimi ve sermaye tahsisi ile kaldıraç olmak üzere dört boyuta dayanır.
Venus Concept Inc kazançlarını ne zaman rapor eder?
Venus Concept Inc'in bir sonraki kazanç raporu 2026-02-11'te bekleniyor